OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a
Yan Xu, Zhuowei Zhou, Xinmei Kang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
Yasi Pan, Huarong Chen, Xiang Zhang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101144-101144
Open Access | Times Cited: 66

METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation
Meilin Xue, Lei Dong, Honghai Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 22

Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling
Kaixin Ding, Zhipeng Zhang, Zhengbin Han, et al.
Science (2025) Vol. 387, Iss. 6737
Closed Access | Times Cited: 2

The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30

MetBil as a novel molecular regulator in ischemia‐induced cardiac fibrosis via METTL3‐mediated m6A modification
Yuting Zhuang, Tingting Li, Xiaoxi Hu, et al.
The FASEB Journal (2023) Vol. 37, Iss. 3
Open Access | Times Cited: 24

m6A modification-tuned sphingolipid metabolism regulates postnatal liver development in male mice
Shiguan Wang, Shanze Chen, Jianfeng Sun, et al.
Nature Metabolism (2023) Vol. 5, Iss. 5, pp. 842-860
Open Access | Times Cited: 24

RNA m6A modification, signals for degradation or stabilisation?
Guifeng Wei
Biochemical Society Transactions (2024) Vol. 52, Iss. 2, pp. 707-717
Open Access | Times Cited: 7

mTOR Signaling Promotes Rapid m6A mRNA Methylation to Regulate NK-Cell Activation and Effector Functions
Meng Meng, Zhaoyang Zhong, Liang Song, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 8, pp. 1039-1057
Closed Access | Times Cited: 7

Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11
Bing Zhou, Yunchen Luo, Hanqi Bi, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2228-2244.e7
Closed Access | Times Cited: 5

N6-methyladenosine modification governs liver glycogenesis by stabilizing the glycogen synthase 2 mRNA
Xiang Zhang, Huilong Yin, Xiaofang Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20

Donor graft METTL3 gene transfer ameliorates rat liver transplantation ischemia-reperfusion injury by enhancing HO-1 expression in an m6A-dependent manner
Song Xiang, Yihua Wang, Dengliang Lei, et al.
Clinical Immunology (2023) Vol. 251, pp. 109325-109325
Closed Access | Times Cited: 11

Loss of Mettl3 enhances liver tumorigenesis by inducing hepatocyte dedifferentiation and hyperproliferation
Tao Wei, Jin Li, Jian Zhang, et al.
Cell Reports (2023) Vol. 42, Iss. 7, pp. 112704-112704
Open Access | Times Cited: 10

Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10

Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access

m6A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury
Shanshan Yu, Xiao Liu, Yan Xu, et al.
Hepatology (2023)
Closed Access | Times Cited: 9

The impact of epitranscriptomic modifications on liver disease
Keith A. Berggren, Robert E. Schwartz, Ralph E. Kleiner, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 4, pp. 331-346
Closed Access | Times Cited: 3

Novel Insights into the Links between N6-Methyladenosine and Regulated Cell Death in Musculoskeletal Diseases
Juanjuan Han, C Wang, Haolin Yang, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 514-514
Open Access | Times Cited: 3

METTL3 Promotes Nucleus Pulposus Cell Senescence in Intervertebral Disc Degeneration by Regulating TLR2 m6A Methylation and Gut Microbiota
Shuangfei Ni, Xiusheng Huang, Xuesen Li, et al.
The Journals of Gerontology Series A (2024) Vol. 79, Iss. 8
Closed Access | Times Cited: 3

RNA epigenetic modifications in digestive tract cancers: Friends or foes
Zekai Nian, Ming Deng, Lele Ye, et al.
Pharmacological Research (2024) Vol. 206, pp. 107280-107280
Open Access | Times Cited: 3

FTO-mediated SMAD2 m6A modification protects cartilage against Osteoarthritis
Hongyi Zhou, Ziang Xie, Yu Qian, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 10, pp. 2283-2295
Open Access | Times Cited: 3

Role of RNA Modifications, Especially m6A, in Aflatoxin Biosynthesis of Aspergillus flavus
Chi Yang, Dandan Wu, Hong Lin, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 72, Iss. 1, pp. 726-741
Closed Access | Times Cited: 7

Regulatory role of m6A epitranscriptomic modifications in normal development and congenital malformations during embryogenesis
Yifan Yao, Peiqi Liu, Yue Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116171-116171
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top